NO20001358L - Mammaglobin, et sekrert brystspesifikt brystkreftprotein - Google Patents

Mammaglobin, et sekrert brystspesifikt brystkreftprotein

Info

Publication number
NO20001358L
NO20001358L NO20001358A NO20001358A NO20001358L NO 20001358 L NO20001358 L NO 20001358L NO 20001358 A NO20001358 A NO 20001358A NO 20001358 A NO20001358 A NO 20001358A NO 20001358 L NO20001358 L NO 20001358L
Authority
NO
Norway
Prior art keywords
mammaglobin
breast cancer
breast
methods
mammoglobin
Prior art date
Application number
NO20001358A
Other languages
English (en)
Other versions
NO20001358D0 (no
Inventor
Mark A Watson
Timothy P Fleming
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of NO20001358D0 publication Critical patent/NO20001358D0/no
Publication of NO20001358L publication Critical patent/NO20001358L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4721—Lipocortins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

En renset og isolert DNA sekvens og det kodede brystspesifikke utskilte proteinet, mammaglobin, er angitt. Også angitt er metoder for å detektere brystkreft basert på overekspresjonen og sekresjonen av mammaglobin av brystkreftceller. Metodene detekterer og/eller kvantiteter nærværet av mammaglobin eller mRNAet som koder for mammaglobin. Immunoterapi- baserte metoder for å behandle en brystkreftpasient med en mammaglobinuttrykkende tumor er også beskrevet. Metodene involverer anvendelsen av mammaglobin- antigener for å indusere en humoral og/eller cellemediert immunrespons mot tumoren.
NO20001358A 1997-09-18 2000-03-15 Mammaglobin, et sekrert brystspesifikt brystkreftprotein NO20001358L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/933,149 US5922836A (en) 1995-05-31 1997-09-18 Mammaglobin antigens
PCT/US1998/017991 WO1999014230A1 (en) 1997-09-18 1998-09-18 Mammaglobin, a secreted mammary-specific breast cancer protein

Publications (2)

Publication Number Publication Date
NO20001358D0 NO20001358D0 (no) 2000-03-15
NO20001358L true NO20001358L (no) 2000-05-12

Family

ID=25463453

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001358A NO20001358L (no) 1997-09-18 2000-03-15 Mammaglobin, et sekrert brystspesifikt brystkreftprotein

Country Status (16)

Country Link
US (1) US5922836A (no)
EP (1) EP1037901A4 (no)
JP (1) JP2001516569A (no)
KR (1) KR20010030617A (no)
CN (1) CN1277614A (no)
AU (1) AU735338B2 (no)
BR (1) BR9812472A (no)
CA (1) CA2304167A1 (no)
HU (1) HUP0004022A2 (no)
IL (1) IL134998A0 (no)
NO (1) NO20001358L (no)
NZ (1) NZ503729A (no)
PL (1) PL340689A1 (no)
TR (2) TR200003685T1 (no)
WO (1) WO1999014230A1 (no)
ZA (1) ZA988526B (no)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566072B1 (en) * 1995-05-31 2003-05-20 Washington University Mammaglobin, a secreted mammary-specific breast cancer protein
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US20040033230A1 (en) * 1997-12-24 2004-02-19 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6528054B1 (en) 1998-12-28 2003-03-04 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US7598226B2 (en) * 1998-12-28 2009-10-06 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6958361B2 (en) * 1998-12-28 2005-10-25 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6969518B2 (en) * 1998-12-28 2005-11-29 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6680197B2 (en) 1998-12-28 2004-01-20 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US6517513B1 (en) * 1999-01-21 2003-02-11 Neomatrix, Llc Intraductal breast fluid aspiration device
AU4469400A (en) * 1999-04-20 2000-11-02 Zymogenetics Inc. Zalpha13: a human secreted protein
US20030045468A1 (en) * 1999-05-28 2003-03-06 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
EP1185557A1 (en) * 1999-05-28 2002-03-13 Corixa Corporation Compositions and methods for the therapy, diagnosis and monitoring of breast cancer
AU5638400A (en) * 1999-06-23 2001-01-09 Corixa Corporation Compositions and methods for the therapy and diagnosis of breast cancer
US20040018570A1 (en) * 1999-09-01 2004-01-29 Brown University Kinase inhibitors and methods of use in screening assays and modulation of cell proliferation and growth
GB9924351D0 (en) 1999-10-14 1999-12-15 Brennan Frank Immunomodulation methods and compositions
US6489101B1 (en) 1999-11-30 2002-12-03 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU1807401A (en) * 1999-11-30 2001-06-12 Corixa Corporation Compositions and methods for therapy and diagnosis of breast cancer
AU2001236911A1 (en) * 2000-02-11 2001-08-20 Corixa Corporation Lipophilin complexes for use in cancer diagnosis and therapy
JP2004505611A (ja) * 2000-04-03 2004-02-26 コリクサ　コーポレイション 乳癌の検出およびモニタリングのための方法、組成物、およびキット
US20030073951A1 (en) * 2001-05-30 2003-04-17 Morton Kevin B. Disposable patient interface for intraductal fluid aspiration system
US6866994B2 (en) 2001-05-30 2005-03-15 Neomatrix, Llc Noninvasive intraductal fluid diagnostic screen
US7247297B2 (en) * 2001-09-14 2007-07-24 The University Of Chicago Use of DF3/MUC1 regulated expression in gene therapy
CA2685308A1 (en) * 2007-04-27 2009-01-29 Dow Global Technologies Inc. Improved production and in vivo assembly of soluble recombinant icosahedral virus-like particles
CN101974088B (zh) * 2010-11-03 2014-04-02 中国人民解放军军事医学科学院基础医学研究所 乳腺珠蛋白单克隆抗体及其在乳腺癌诊断中的应用
US8795359B2 (en) 2012-06-13 2014-08-05 Elwha Llc Breast implant with regionalized analyte sensors and internal power source
US9211185B2 (en) 2012-06-13 2015-12-15 Elwha Llc Breast implant with analyte sensors and internal power source
US9144488B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with analyte sensors responsive to external power source
US8808373B2 (en) 2012-06-13 2014-08-19 Elwha Llc Breast implant with regionalized analyte sensors responsive to external power source
US9144489B2 (en) 2012-06-13 2015-09-29 Elwha Llc Breast implant with covering, analyte sensors and internal power source
US8790400B2 (en) 2012-06-13 2014-07-29 Elwha Llc Breast implant with covering and analyte sensors responsive to external power source
KR101603400B1 (ko) * 2014-02-04 2016-03-14 경상대학교산학협력단 맘마글로빈을 포함하는 암전이 억제용 조성물

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US573916A (en) * 1896-12-29 Threshing-machine
US5593972A (en) * 1993-01-26 1997-01-14 The Wistar Institute Genetic immunization
US5610031A (en) * 1993-10-27 1997-03-11 The General Hospital Corporation B1k chain of laminin and methods of use
US5573916A (en) * 1994-05-19 1996-11-12 Coretech, Inc. Immunogenic constructs comprising b-cell and t-cell epitopes on common carrier
US5922836A (en) * 1995-05-31 1999-07-13 Washington University Mammaglobin antigens
US5668267A (en) * 1995-05-31 1997-09-16 Washington University Polynucleotides encoding mammaglobin, a mammary-specific breast cancer protein
EP0856010A1 (en) * 1996-08-19 1998-08-05 Abbott Laboratories Mammaglobin, antibodies thereto, and their use for detecting diseases of the breast

Also Published As

Publication number Publication date
NO20001358D0 (no) 2000-03-15
NZ503729A (en) 2001-12-21
US5922836A (en) 1999-07-13
TR200003685T1 (tr) 2001-04-20
AU735338B2 (en) 2001-07-05
CA2304167A1 (en) 1999-03-25
WO1999014230A1 (en) 1999-03-25
JP2001516569A (ja) 2001-10-02
EP1037901A1 (en) 2000-09-27
BR9812472A (pt) 2000-09-19
KR20010030617A (ko) 2001-04-16
PL340689A1 (en) 2001-02-26
IL134998A0 (en) 2001-05-20
ZA988526B (en) 1999-08-16
AU9373798A (en) 1999-04-05
CN1277614A (zh) 2000-12-20
TR200001646T2 (tr) 2000-10-23
EP1037901A4 (en) 2003-07-16
HUP0004022A2 (en) 2001-03-28

Similar Documents

Publication Publication Date Title
TR200003685T1 (tr) Bir salgılanmış meme kanseri proteini olan mamaglobin
NO975508D0 (no) DNA-sekvens og kodet bryst- spesifikk brystkreftprotein
AU3607301A (en) Gene recombinant antibody and its fragment
DE69632536D1 (de) Impfstoffe für das respiratorische-synzytial-virus mit nuklein säuren
AU2001253079A1 (en) Methods, compositions and kits for the detection and monitoring of breast cancer
NO20011394L (no) Mammoglobin, et sekrert brystspesifikt brystkreftprotein
WO2001040269A3 (en) Compositions and methods for therapy and diagnosis of breast cancer
NZ512247A (en) Compositions and methods for therapy and diagnosis of ovarian cancer
DE69839273D1 (de) Krebs immuntherapie mit semi-allogenen zellen
DK1854809T3 (da) Nukleinsyre og tilsvarende protein betegnet 158P1D7, der er anvendelig i behandling og påvisning af blærecancer og andre cancere
ATE205532T1 (de) Zellzyklus-unabhängige, gliomaoberflach- spezifische, menschliche monoklonale antikörper
WO2001018046A3 (en) Ovarian tumor sequences and methods of use therefor
ATE316577T1 (de) Das goodpasture-antigen bindende protein
WO2000078960A3 (en) Compositions and methods for the therapy and diagnosis of breast cancer
WO2001079557A3 (en) Gtp-binding protein useful in treatment and detection of cancer
BR0012446A (pt) Proteìna da rede de leitura alternativa do receptory de células t e uso da mesma
ATE501255T1 (de) 84p2a9: prostata- und hodenspezifisches protein, das sehr stark bei prostatakrebs vorkommt
DK1313850T3 (da) Nucleinsyre og tilsvarende protein med navnet 85PB3 anvendelige til behandling og påvisning af cancer
WO2004034995A3 (en) Methods and reagents for inducing immunity
WO2003020954A3 (en) 205p1b5 in treatment and detection of cancer
NO914094L (no) Nytt monoklonalt antistoff mot nytt antigen forbundet medhumantumorer
ATE537257T1 (de) Mit iga-nephropathie assoziierte dns
DE59712247D1 (de) Mammakarzinom-assoziiertes gen
CY1113516T1 (el) Νουκλεϊκο οξυ και αντιστοιχη πρωτεϊνη με ονομασια 158p1d7 χρησιμα στην αγωγη και ανιχνευση καρκινου ουροδοχου κυστης και αλλων καρκινων
CY1113332T1 (el) Νουκλεϊκα οξεα και αντιστοιχες πρωτεϊνες με ονομασια 191p4d12(b) χρησιμα στην αγωγη και ανιχνευση καρκινου

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application